Calaptin standard release contains the active ingredient verapamil hydrochloride. This calcium ion influx inhibitor causes blood vessels to relax so that blood can flow more easily around your body. It is indicated for the treatment of hypertension to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Management of high blood pressure should be a part of comprehensive cardiovascular risk management, including, as appropriate, diabetes management, lipid control, exercise, smoking cessation, and limited sodium intake. Many patients require more than one medicine to achieve blood pressure goals. For specific advice on goals and management, contact your doctor. Verapamil can be used as an initial agent in patients with beta-blockers. Diuretics are contraindicated in patients with medical conditions where these drugs frequently cause serious side effects.
Reviews
There are no reviews yet.